Drug Profile
Research programme: anti-infectives - Bio-Rad Laboratories/Dana Farber Cancer Institute
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator AbD Serotec; Dana-Farber Cancer Institute
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Viral-infections in USA
- 10 Jan 2013 AbD Serotec has been acquired by Bio-Rad Laboratories
- 25 Jul 2011 Early research in Viral infections in USA (unspecified route)